| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 41.233 | 87.953 | 134.881 | 163.750 | 198.540 |
| Total Income - EUR | - | - | - | 0 | 0 | 41.261 | 96.039 | 134.897 | 163.965 | 198.540 |
| Total Expenses - EUR | - | - | - | 0 | 0 | 6.815 | 33.931 | 23.151 | 21.521 | 32.762 |
| Gross Profit/Loss - EUR | - | - | - | 0 | 0 | 34.446 | 62.107 | 111.747 | 142.444 | 165.778 |
| Net Profit/Loss - EUR | - | - | - | 0 | 0 | 33.786 | 60.962 | 108.372 | 140.804 | 159.821 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medprime Ray S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 12.146 | 0 | 0 | 30.486 | 23.320 |
| Current Assets | - | - | - | 43 | 42 | 22.146 | 94.398 | 109.691 | 117.154 | 145.290 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 64.062 | 109.665 | 143.977 |
| Cash | - | - | - | 43 | 42 | 22.146 | 94.398 | 45.630 | 7.488 | 1.313 |
| Shareholders Funds | - | - | - | 43 | 42 | 33.831 | 94.043 | 108.426 | 140.858 | 160.247 |
| Social Capital | - | - | - | 43 | 42 | 45 | 44 | 45 | 44 | 44 |
| Debts | - | - | - | 0 | 0 | 460 | 355 | 1.265 | 6.782 | 8.362 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Medprime Ray S.r.l.